Boehringer Ingelheim Secures CVMP Positive Opinion for Vaxxitek HVT+IBD+H5 and Vaxxinact H5 Vaccines Against Avian Influenza
Shots:
- The CVMP has recommended Vaxxitek HVT+IBD+H5 & Vaxxinact H5 for active immunization of birds against H5 avian influenza virus
- Vaxxitek HVT+IBD+H5 is a trivalent vaccine providing single-dose protection against Marek’s disease, Infectious Bursal Disease, & H5 avian influenza in chickens & turkeys, while Vaxxinact H5 is an inactivated vaccine that protects chickens, turkeys, & ducks against H5 avian influenza
- Vaxxitek HVT+IBD+H5 & Vaxxinact H5 are also Differentiate Infected from Vaccinated Animals (DIVA) vaccines that use biomarkers to distinguish vaccine-induced immunity from infection antibodies, supporting outbreak monitoring & helping reduce trade restrictions
Ref: Boehringer Ingelheim | Image: Boehringer Ingelheim| Press Release
Related News:- Boehringer Ingelheim and CDR-Life Expand their Partnership with a Global Licensing Deal for CDR111
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com


